Gran Plasa
2
4M
2
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Switzerland. The leading representative office of defined VC is situated in the Fribourg.
Among the various public portfolio startups of the fund, we may underline NanoPowers, Myopowers Medical Technologies, Myopowers Medical Technologies The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical Device, Health Care. For fund there is no match between the location of its establishment and the land of its numerous investments - France. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Gran Plasa, startups are often financed by Truffle Capital, Novartis Venture Fund, BlueOcean Ventures. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Truffle Capital, DEFI Gestion. In the next rounds fund is usually obtained by Truffle Capital, Novartis Venture Fund.
The high activity for fund was in 2015. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Investments by industry
- Health Care (2)
- Biotechnology (2)
- Medical Device (1)
- Health Diagnostics (1)
- Investments by region
-
- France (1)
- Switzerland (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Myopowers Medical Technologies | 16 Jun 2015 | Biotechnology, Health Care, Health Diagnostics | Late Stage Venture | 5M | France, Bourgogne-Franche-Comté, Besançon |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.